Digital Otoscope Versus Education and Feedback for Otitis Media in Young Children
Effect of Education and Feedback, Wispr Digital Otoscope, or Both on Antibiotic Prescribing Patterns for Otitis Media in Young Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jane Gould, MPH
- Phone Number: 617-919-4073
- Email: jane.bittner@childrens.harvard.edu
Study Contact Backup
- Name: Louis Vernacchio, MD, MSc
- Phone Number: 617-919-4073
- Email: louis.vernacchio@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Wellesley, Massachusetts, United States, 02115
- Pediatric Physicians' Organization at Children's
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pediatric primary care clinicians from the Pediatric Physicians' Organization at Children's with an Otitis Media Treatment Index for the previous 12 months in the top quartile of all Pediatric Physicians' Organization at Children's clinicians with at least 100 qualifying encounters in the year
Exclusion Criteria:
- Currently using any digital otoscope
- More than one other clinician from the same practice participating in the trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Control arm, no intervention
|
|
|
Experimental: Education with personalized performance feedback
Education about proper otitis media diagnosis following criteria from the American Academy of Pediatrics with personalized performance feedback on otitis media diagnosis and treatment rates delivered via email
|
Education about proper otitis media diagnosis following criteria from the American Academy of Pediatrics with personalized performance feedback on otitis media diagnosis and treatment rates delivered via email
Other Names:
|
|
Experimental: Use of digital otoscope
Use of the Wispr digital otoscope to diagnose otitis media in place of a traditional visual otoscope
|
Use of the Wispr digital otoscope to diagnose otitis media in place of a traditional visual otoscope
|
|
Experimental: Education with personalized performance feedback plus use of a digital otoscope
Education about proper otitis media diagnosis following criteria from the American Academy of Pediatrics with personalized performance feedback on otitis media diagnosis and treatment rates delivered via email plus use of the Wispr digital otoscope to diagnose otitis media in place of a traditional visual otoscope
|
Education about proper otitis media diagnosis following criteria from the American Academy of Pediatrics with personalized performance feedback on otitis media diagnosis and treatment rates delivered via email
Other Names:
Use of the Wispr digital otoscope to diagnose otitis media in place of a traditional visual otoscope
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in OMTI
Time Frame: 3 months
|
Proportion of encounters in children 6-59 months of age with any respiratory diagnosis who are diagnosed with otitis media and treated with a systemic antibiotic.
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in overall antibiotic courses prescribed
Time Frame: 3 months
|
Courses of systemic antibiotics per 1000 children per year among children 6-59 months of age.
|
3 months
|
|
Change in overall prescribed antibiotic days
Time Frame: 3 months
|
Total days of systemic antibiotics per 1000 children per year among children 6-59 months of age.
|
3 months
|
|
Clinician confidence and satisfaction in diagnosing OM and preference for digital versus traditional otoscope
Time Frame: 3 months
|
Clinician responses to a pre- and post-intervention surveys regarding confidence in diagnosing otitis media and satisfaction with digital versus traditional otoscope.
|
3 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return respiratory illness visits within 7 days (balancing measure)
Time Frame: 3 months
|
Proportion of patients with an index encounter with respiratory diagnosis who return to the primary care office for a visit with a respiratory diagnosis within 7 days of the index visit.
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Louis Vernacchio, MD, MSc, Pediatric Physicians' Organization at Children's
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P00049513
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.